1. Home
  2. Author
  3. Lipschitz S

Lipschitz S

References (2)

Title : Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial - Dubois_2023_Alzheimers.Res.Ther_15_39
Author(s) : Dubois B , Lopez-Arrieta J , Lipschitz S , Triantafyllos D , Spiru L , Moroz S , Venger O , Vermersch P , Moussy A , Mansfield CD , Hermine O , Tsolaki M
Ref : Alzheimers Res Ther , 15 :39 , 2023
Abstract : Dubois_2023_Alzheimers.Res.Ther_15_39
ESTHER : Dubois_2023_Alzheimers.Res.Ther_15_39
PubMedSearch : Dubois_2023_Alzheimers.Res.Ther_15_39
PubMedID: 36849969

Title : Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study - Florian_2016_J.Alzheimers.Dis_51_1237
Author(s) : Florian H , Meier A , Gauthier S , Lipschitz S , Lin Y , Tang Q , Othman AA , Robieson WZ , Gault LM
Ref : J Alzheimers Dis , 51 :1237 , 2016
Abstract : Florian_2016_J.Alzheimers.Dis_51_1237
ESTHER : Florian_2016_J.Alzheimers.Dis_51_1237
PubMedSearch : Florian_2016_J.Alzheimers.Dis_51_1237
PubMedID: 26967214